Literature DB >> 21081124

Crucial role of the influenza virus NS2 (NEP) C-terminal domain in M1 binding and nuclear export of vRNP.

Teppei Shimizu1, Naoki Takizawa, Ken Watanabe, Kyosuke Nagata, Nobuyuki Kobayashi.   

Abstract

The influenza virus genome replicates in the host cell nucleus, and the progeny viral ribonucleoproteins (vRNPs) are exported to the cytoplasm prior to maturation. The influenza virus NS2 protein has a nuclear export signal (NES) and binds to M1. It is therefore postulated that vRNP is exported from the nucleus by binding to NS2 through M1. However, the significance of the association between NS2 and M1 for the nuclear export of vRNP is still poorly understood. We herein demonstrate that the C-terminal domain of NS2 (residues 81-100) is essential for M1 binding and the nuclear export of progeny vRNPs.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21081124     DOI: 10.1016/j.febslet.2010.11.017

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  36 in total

1.  Human immunodeficiency virus rev-binding protein is essential for influenza a virus replication and promotes genome trafficking in late-stage infection.

Authors:  Amie J Eisfeld; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

2.  Intracellular expression of camelid single-domain antibodies specific for influenza virus nucleoprotein uncovers distinct features of its nuclear localization.

Authors:  Joseph Ashour; Florian I Schmidt; Leo Hanke; Juanjo Cragnolini; Marco Cavallari; Arwen Altenburg; Rebeccah Brewer; Jessica Ingram; Charles Shoemaker; Hidde L Ploegh
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

3.  Selective incorporation of vRNP into influenza A virions determined by its specific interaction with M1 protein.

Authors:  Chutikarn Chaimayo; Tsuyoshi Hayashi; Andrew Underwood; Erin Hodges; Toru Takimoto
Journal:  Virology       Date:  2017-02-17       Impact factor: 3.616

4.  A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication.

Authors:  Shuai Cao; Xiaoling Liu; Maorong Yu; Jing Li; Xiaojuan Jia; Yuhai Bi; Lei Sun; George F Gao; Wenjun Liu
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

5.  Identification of host genes linked with the survivability of chickens infected with recombinant viruses possessing H5N1 surface antigens from a highly pathogenic avian influenza virus.

Authors:  Yuko Uchida; Chiaki Watanabe; Nobuhiro Takemae; Tsuyoshi Hayashi; Takehiko Oka; Toshihiro Ito; Takehiko Saito
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

6.  CypA Regulates AIP4-Mediated M1 Ubiquitination of Influenza A Virus.

Authors:  Madina Mahesutihan; Weinan Zheng; Liang Cui; Yun Li; Pengtao Jiao; Wenxian Yang; Wei Liu; Jing Li; Wenhui Fan; Limin Yang; Wenjun Liu; Lei Sun
Journal:  Virol Sin       Date:  2018-10-16       Impact factor: 4.327

Review 7.  At the centre: influenza A virus ribonucleoproteins.

Authors:  Amie J Eisfeld; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Nat Rev Microbiol       Date:  2014-11-24       Impact factor: 60.633

8.  Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection.

Authors:  Mark A Chua; Sonja Schmid; Jasmine T Perez; Ryan A Langlois; Benjamin R Tenoever
Journal:  Cell Rep       Date:  2013-01-17       Impact factor: 9.423

9.  A crucial role of N-terminal domain of influenza A virus M1 protein in interaction with swine importin α1 protein.

Authors:  Qinfang Liu; Bhupinder Bawa; Jingjiao Ma; Feng Li; Wenjun Ma; Jürgen A Richt
Journal:  Virus Genes       Date:  2014-04-18       Impact factor: 2.332

10.  Possibility of cross-species/subtype reassortments in influenza A viruses: an analysis of nonstructural protein variations.

Authors:  Shaomin Yan; Guang Wu
Journal:  Virulence       Date:  2013-10-08       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.